AZN vs GSK: Side-by-Side Comparison
Compare Astrazeneca plc (AZN) and GSK Plc (GSK) side by side: market cap USD 302.65B vs USD 107.63B, P/E 58.6 vs 14.0. Financials, growth and model signals on Bullrun.
| Metric | AZN | GSK |
|---|---|---|
| Company | Astrazeneca plc | GSK Plc |
| Country / Exchange | United Kingdom · NASDAQ | United Kingdom · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 302.65B | USD 107.63B |
| P/E ratio | 58.6 | 14.0 |
| Dividend yield | 1.63% | 3.34% |
| Valuation model | 29.8% overvalued | 36.9% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |